(Boursier.com) — Mithras a company dedicated to women’s health, announces today that after a careful evaluation of several firm offers, Mithra has accepted the offer submitted by Gedeon Richter, which concerns Estetra SRL, Neuralis SA and the specific assets held by Mithra R&D SA linked to the E4 platform, as a basis for further negotiations, and has decided to grant exclusivity to Gedeon Richter for the purposes of these negotiations (until May 10, 2024 at the last, unless extended).
Although this step reflects a positive development towards the sale of the assets, Mithra reiterates that, as it stands, the total amount of the offer (as well as other offers received regarding assets outside the envisaged scope of the Gedeon Richter’s offer) is insufficient to ensure full repayment of all Mithra creditors and will therefore not create value for Mithra shareholders.
Mithra remains committed to negotiating with potential buyers to increase value, acting in the best interests of all stakeholders (see also the press release of April 29, 2024 on this subject).
Trading in Mithra shares on Euronext Brussels remains suspended pending ongoing negotiations.
©2024 Boursier.com